Literature DB >> 27998215

Psychoeducational Intervention to Reduce Fear of Cancer Recurrence in People at High Risk of Developing Another Primary Melanoma: Results of a Randomized Controlled Trial.

Mbathio Dieng1, Phyllis N Butow1, Daniel S J Costa1, Rachael L Morton1, Scott W Menzies1, Shab Mireskandari1, Stephanie Tesson1, Graham J Mann1, Anne E Cust1, Nadine A Kasparian1.   

Abstract

Purpose People with a history of melanoma commonly report a fear of cancer recurrence (FCR), yet psychologic support is not routinely offered as part of ongoing melanoma care. This randomized controlled trial examined the efficacy of a psychoeducational intervention to reduce FCR and improve psychologic adjustment in this patient group compared with usual care. Methods The intervention comprised a newly developed psychoeducational resource and three telephone-based psychotherapeutic sessions over a 1-month period timed in accordance with dermatologic appointments. Participants were randomly assigned to intervention (n = 80) or usual care (n = 84). Assessments were completed at baseline, 1 month, and 6 months after dermatologic appointments. Linear mixed models were used to examine differences between treatment and control groups for patient-reported outcomes, including FCR, anxiety, stress, depression, melanoma-related knowledge, health behaviors, satisfaction with melanoma care, unmet needs, and health-related quality of life. Results At 6 months, the intervention group reported lower FCR severity, trigger, and distress scores than the control group in the baseline-adjusted models; the between-group mean difference was -1.9 for FCR severity (95% CI, -3.1 to -0.7; P = .002), -2.0 for FCR triggers (95% CI, -3.3 to -0.7; P = .003), and -0.7 for FCR distress (95% CI, -1.3 to -0.1; P = .03). The decrease in FCR severity (but not triggers or distress) remained statistically significant after adjustment for other covariates ( P = .04). At 6 months, the intervention group also reported lower stress (-1.6; 95% CI, -3.1 to -0.2; P = .03) and improved melanoma-related knowledge (1.7; 95% CI, 0.8 to 2.6; P < .001) compared with the control group. No differences were found between groups for other secondary outcomes. Conclusion This newly developed evidence-based psychoeducational intervention was effective in reducing FCR and stress and increasing melanoma-related knowledge in people at high risk for another melanoma.

Entities:  

Mesh:

Year:  2016        PMID: 27998215     DOI: 10.1200/JCO.2016.68.2278

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  31 in total

1.  Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.

Authors:  Allan 'Ben' Smith; Louise Sharpe; Belinda Thewes; Jane Turner; Jemma Gilchrist; Joanna E Fardell; Afaf Girgis; Stephanie Tesson; Joseph Descallar; Melanie L Bell; Jane Beith; Phyllis Butow
Journal:  Support Care Cancer       Date:  2018-06-07       Impact factor: 3.603

2.  Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.

Authors:  Mbathio Dieng; Nadine A Kasparian; Anne E Cust; Daniel S J Costa; Anh Tran; Phyllis N Butow; Scott W Menzies; Graham J Mann; Rachael L Morton
Journal:  JAMA Dermatol       Date:  2018-01-01       Impact factor: 10.282

3.  Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial.

Authors:  Shelley A Johns; Patrick V Stutz; Tasneem L Talib; Andrea A Cohee; Kathleen A Beck-Coon; Linda F Brown; Laura R Wilhelm; Patrick O Monahan; Michelle L LaPradd; Victoria L Champion; Kathy D Miller; R Brian Giesler
Journal:  Cancer       Date:  2019-09-20       Impact factor: 6.860

Review 4.  Interventions to enhance self-efficacy in cancer patients: A meta-analysis of randomized controlled trials.

Authors:  Thomas V Merluzzi; James E Pustejovsky; Errol J Philip; Stephanie J Sohl; Mark Berendsen; John M Salsman
Journal:  Psychooncology       Date:  2019-07-09       Impact factor: 3.894

5.  Enhancing coping skills for persons with cancer utilizing mastery enhancement: a pilot randomized clinical trial.

Authors:  Raymond C Nairn; Thomas V Merluzzi
Journal:  J Behav Med       Date:  2018-12-14

6.  Psychological intervention (ConquerFear) for treating fear of cancer recurrence: mediators and moderators of treatment efficacy.

Authors:  Louise Sharpe; J Turner; J E Fardell; B Thewes; A B Smith; J Gilchrist; J Beith; A Girgis; S Tesson; S Day; K Grunewald; P Butow
Journal:  J Cancer Surviv       Date:  2019-07-25       Impact factor: 4.442

7.  The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors.

Authors:  Julia Lai-Kwon; Chloe Khoo; Serigne Lo; Donna Milne; Mustafa Mohamed; Jeanette Raleigh; Kortnye Smith; Karolina Lisy; Shahneen Sandhu; Michael Jefford
Journal:  J Cancer Surviv       Date:  2019-06-04       Impact factor: 4.442

Review 8.  The relationship between fears of cancer recurrence and patient age: A systematic review and meta-analysis.

Authors:  Edward Lim; Gerald Humphris
Journal:  Cancer Rep (Hoboken)       Date:  2020-02-20

9.  Telephone interventions for symptom management in adults with cancer.

Authors:  Emma Ream; Amanda Euesden Hughes; Anna Cox; Katy Skarparis; Alison Richardson; Vibe H Pedersen; Theresa Wiseman; Angus Forbes; Andrew Bryant
Journal:  Cochrane Database Syst Rev       Date:  2020-06-02

10.  Associations among physical symptoms, fear of cancer recurrence, and emotional well-being among Chinese American breast cancer survivors: a path model.

Authors:  Dalnim Cho; Qiao Chu; Qian Lu
Journal:  Support Care Cancer       Date:  2017-12-14       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.